Delivery Order SPE2DR25D1053-SPE2DR26FV122
- Not listed
- The Defense Logistics Agency awarded a $1,059.48 delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count) on December 11, 2025, with completion scheduled for December 12, 2025. This competitively awarded, firm fixed-price delivery order reflects AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply chain, serving military and veteran healthcare systems. The contract was performed at the company's...
- The Defense Logistics Agency awarded a $2,206.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count supply) on August 21, 2025, with completion scheduled for August 22, 2025. This non-competitive delivery order was issued from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,677.96 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count unit) on November 18, 2025, with completion targeted for November 19, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating open competitive procurement. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this delivery order through its Corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,868.75 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-pack unit) on September 29, 2025, with completion scheduled for September 30, 2025. The contract utilized firm fixed price pricing with no set-aside designation, indicating competitive award through open competition. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its...
- The Defense Logistics Agency awarded a delivery order valued at $3,860.10 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count). This firm fixed price, non-competitive delivery order was issued on September 24, 2025, with an ultimate completion date of September 25, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $2,160.14 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-unit supply), with an ultimate completion date of December 19, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement and represents a routine pharmaceutical procurement from the vendor's extensive portfolio of federal medical supplies. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,428.13 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-pack units). This competitively awarded, non-set-aside delivery order reflects firm fixed pricing and is scheduled for completion by July 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location. This delivery order...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $11,136.91 for Xulane 150-35 mcg/day contraceptive patches (3-count units) on July 2, 2025, with an ultimate completion date of July 3, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $1,968.36 to AmerisourceBergen Drug Corp for Xulane 150-35 micrograms per day contraceptive patches (3-pack units) on December 12, 2025, with a completion date of December 15, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $1,066.88 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-pack quantity) on December 3, 2025, with completion scheduled for December 4, 2025. This firm fixed-price delivery order was awarded without set-aside restrictions through open competition and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transactional purchase under...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV122Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,035.31 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count package) with an ultimate completion date of January 2, 2026. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award reflects the agency's ongoing pharmaceutical procurement needs for military and federal healthcare systems. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical vendor in the federal medical supply chain, AmerisourceBergen leverages this comprehensive IDC to deliver a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other government health systems worldwide. The company's consistent track record of competitively awarded contracts demonstrates its capability to meet federal procurement requirements across diverse therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 12/30/25 |